{"data":{"id":962,"lang":"en","title":"Scientists Engineer Probiotic Bacteria to Infiltrate Tumors and Produce Cancer Drugs on Site","summary":"Chinese researchers engineered probiotic bacteria to produce cancer drugs directly inside tumors in mice, offering a targeted alternative to traditional chemotherapy.","category":"science","category_label":"Science","published_at":"2026-03-22T05:02:43Z","updated_at":"2026-03-22T05:02:43Z","url":"https://techtools.cz/tools/news/article/962-scientists-engineer-probiotic-bacteria-to-infiltrate-tumors-and-produce-cancer","api_url":"https://techtools.cz/news-api/v1/articles/962?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/962.md?lang=en","image_url":"https://scx2.b-cdn.net/gfx/news/hires/2026/engineered-bacteria-de.jpg","word_count":151,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260321004445.htm","domain":"sciencedaily.com"},{"url":"https://medicalxpress.com/news/2026-03-bacteria-cancer-drug-tumors-mice.html","domain":"medicalxpress.com"}],"translation":{"lang":"cs","id":995,"title":"Vědci upravili probiotické bakterie, aby pronikly do nádorů a vyráběly protirakovinné léky přímo na místě","url":"https://techtools.cz/tools/news/clanek/995-vedci-upravili-probioticke-bakterie-aby-pronikly-do-nadoru-a-vyrabely","api_url":"https://techtools.cz/news-api/v1/articles/995?lang=cs"},"content":"Researchers at Shandong University in China have engineered the probiotic bacterium E. coli Nissle 1917 to function as a living drug factory inside tumors. The modified bacteria produce Romidepsin (FK228), an FDA-approved anticancer compound, directly at tumor sites. In mouse models with breast cancer, the engineered probiotics successfully accumulated inside tumors and released the drug under controlled conditions.\n\nThe approach represents a shift from traditional chemotherapy, which floods the entire body with toxic drugs. By delivering medication precisely where it is needed, the bacterial system could reduce side effects while increasing the drug concentration at the tumor. The study, published March 17 in PLOS Biology, showed the bacteria worked effectively in both laboratory and live animal settings.\n\nThe research is still in early stages and has not been tested in humans. Future studies will need to evaluate safety, potential side effects, and strategies for removing the bacteria after treatment is complete."}}